Literature DB >> 18215208

Charcot-Marie-Tooth disease: a clinico-genetic confrontation.

N Barisic1, K G Claeys, M Sirotković-Skerlev, A Löfgren, E Nelis, P De Jonghe, V Timmerman.   

Abstract

Charcot-Marie-Tooth disease (CMT) is the most common neuromuscular disorder. It represents a group of clinically and genetically heterogeneous inherited neuropathies. Here, we review the results of molecular genetic investigations and the clinical and neurophysiological features of the different CMT subtypes. The products of genes associated with CMT phenotypes are important for the neuronal structure maintenance, axonal transport, nerve signal transduction and functions related to the cellular integrity. Identifying the molecular basis of CMT and studying the relevant genes and their functions is important to understand the pathophysiological mechanisms of these neurodegenerative disorders, and the processes involved in the normal development and function of the peripheral nervous system. The results of molecular genetic investigations have impact on the appropriate diagnosis, genetic counselling and possible new therapeutic options for CMT patients.

Entities:  

Mesh:

Year:  2008        PMID: 18215208     DOI: 10.1111/j.1469-1809.2007.00412.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  52 in total

1.  Expressing hNF-LE397K results in abnormal gaiting in a transgenic model of CMT2E.

Authors:  J M Dale; E Villalon; S G Shannon; D M Barry; R M Markey; V B Garcia; M L Garcia
Journal:  Genes Brain Behav       Date:  2012-02-23       Impact factor: 3.449

Review 2.  Role of Rab GTPases in membrane traffic and cell physiology.

Authors:  Alex H Hutagalung; Peter J Novick
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening.

Authors:  Weiwei He; Hui-Min Zhang; Yeeting E Chong; Min Guo; Alan G Marshall; Xiang-Lei Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-07       Impact factor: 11.205

Review 4.  Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases.

Authors:  Craig M McDonald
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

5.  Cthrc1 is a negative regulator of myelination in Schwann cells.

Authors:  Caroline Apra; Laurence Richard; Fanny Coulpier; Corinne Blugeon; Pascale Gilardi-Hebenstreit; Jean-michel Vallat; Volkhard Lindner; Patrick Charnay; Laurence Decker
Journal:  Glia       Date:  2012-03       Impact factor: 7.452

Review 6.  Rab GTPases, membrane trafficking and diseases.

Authors:  Guangpu Li
Journal:  Curr Drug Targets       Date:  2011-07-01       Impact factor: 3.465

7.  Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model.

Authors:  Cristina Scapin; Cinzia Ferri; Emanuela Pettinato; Desiree Zambroni; Francesca Bianchi; Ubaldo Del Carro; Sophie Belin; Donatella Caruso; Nico Mitro; Marta Pellegatta; Carla Taveggia; Markus H Schwab; Klaus-Armin Nave; M Laura Feltri; Lawrence Wrabetz; Maurizio D'Antonio
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

8.  Defective axonal transport of Rab7 GTPase results in dysregulated trophic signaling.

Authors:  Kai Zhang; Rotem Fishel Ben Kenan; Yasuko Osakada; Wei Xu; Rachel S Sinit; Liang Chen; Xiaobei Zhao; Jia-Yun Chen; Bianxiao Cui; Chengbiao Wu
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

9.  Increased monomerization of mutant HSPB1 leads to protein hyperactivity in Charcot-Marie-Tooth neuropathy.

Authors:  Leonardo Almeida-Souza; Sofie Goethals; Vicky de Winter; Ines Dierick; Rodrigo Gallardo; Joost Van Durme; Joy Irobi; Jan Gettemans; Frederic Rousseau; Joost Schymkowitz; Vincent Timmerman; Sophie Janssens
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

10.  Disease mutations in Rab7 result in unregulated nucleotide exchange and inappropriate activation.

Authors:  Brett A McCray; Emmanuel Skordalakes; J Paul Taylor
Journal:  Hum Mol Genet       Date:  2009-12-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.